Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis--who should be candidates for interventional treatment? Authors' reply

Martin Rössle^{1

2}, Dominik Bettinger^{1

3}, Robert Thimme¹, Michael Schultheiss¹

Affiliations

¹ Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, University of Freiburg, Freiburg, Germany.
² PraxisZentrum für Gastroenterologie und Endokrinologie, Freiburg, Germany.
³ Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Editorial

Martin Rössle et al. Aliment Pharmacol Ther. 2020 Aug.

. 2020 Aug;52(4):729-730.

doi: 10.1111/apt.15930.

Martin Rössle^{1

2}, Dominik Bettinger^{1

3}, Robert Thimme¹, Michael Schultheiss¹

¹ Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, University of Freiburg, Freiburg, Germany.
² PraxisZentrum für Gastroenterologie und Endokrinologie, Freiburg, Germany.
³ Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

No abstract available

Comment on

A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment.
Rössle M, Bettinger D, Trebicka J, Klinger C, Praktiknjo M, Sturm L, Caca K, Mücke VT, Radecke K, Engelmann C, Zipprich A, Heinzow H, Meyer C, Tappe U, Appenrodt B, Schmidt A, Lange C, Strassburg C, Zeuzem S, Grandt D, Schmidt H, Moessner J, Berg T, Lammert F, Thimme R, Schultheiß M. Rössle M, et al. Aliment Pharmacol Ther. 2020 Jul;52(2):329-339. doi: 10.1111/apt.15811. Epub 2020 Jun 7. Aliment Pharmacol Ther. 2020. PMID: 32506456
Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis-who should be candidates for interventional treatment?
Zhang D, Xu S, Tian Y, Qi X. Zhang D, et al. Aliment Pharmacol Ther. 2020 Aug;52(4):725-728. doi: 10.1111/apt.15902. Aliment Pharmacol Ther. 2020. PMID: 32886391 No abstract available.